bpc 157 dosing and frequency BPC-157: Benefits & Dosage Guide Dose Of Bpc 157 And

That difference is absolute

Read more about Dr Mignonne C

There is no need to stop AOD-9604 unless you want to simplify your protocol while troubleshooting

References Allen LH

Research in rodent SCI models (clip compression, transection, contusion) demonstrates: Improved functional research applications (Basso-Beattie-Bresnahan locomotor rating scale scores) in BPC-157-treated animals compared to vehicle controls Reduced lesion volume at chronic timepoints, suggesting neuroprotection of spared tissue in the penumbra zone Enhanced axonal regrowth markers (GAP-43, growth-associated protein-43) in the injury zone Reduced glial scar (GFAP-positive astrocytic reactivity) at the lesion boundary a significant finding given that glial scar formation is the primary physical barrier to axonal regeneration The angiogenic mechanism of BPC-157 (VEGF stimulation, endothelial tube formation) is particularly relevant to SCI research: the spinal cord is highly vascular, and ischaemic secondary injury following disruption of spinal vasculature drives extensive secondary neurodegeneration